Quick Answer
Galera Therapeutics, Inc. reported Shares Outstanding of 75.46 million shares for fiscal year 2025.
Galera Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 75.46M | +0.0% |
| 2024 | 75.46M | +38.7% |
| 2023 | 54.39M | +90.8% |
| 2022 | 28.51M | +7.8% |
| 2021 | 26.46M | +5.9% |
| 2020 | 24.98M | +0.7% |
| 2019 | 24.81M | +8154.1% |
| 2018 | 300,597 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 75.46M | +38.7% | +0.0% |
| June 30, 2025 | 75.46M | +38.7% | +0.0% |
| March 31, 2025 | 75.46M | +38.7% | +0.0% |
| December 31, 2024 | 75.46M | +38.7% | +38.7% |
| September 30, 2024 | 54.39M | +1.2% | +0.0% |
| June 30, 2024 | 54.39M | +24.1% | +0.0% |
| March 31, 2024 | 54.39M | +26.8% | +0.0% |
| December 31, 2023 | 54.39M | +90.8% | +1.2% |
- Galera Therapeutics, Inc. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2025 period, Galera Therapeutics, Inc.’s shares outstanding has grown by 25004.2% (from 300.6 thousand shares to 75.46 million shares).
- The most recent figure is from Galera Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: